HRS Aluglaze Share Price Hits 5% Upper Circuit on Plans to Set Up Glass Glazing Plant in Ahmedabad

HRS Aluglaze, a manufacturer of aluminium products, has announced its decision to establish a glass glazing manufacturing facility in Ahmedabad, Gujarat. The investment for this facility is estimated at ₹16 crore and forms part of the company’s larger growth strategy. 

New Facility to Enhance Façade Production 

The Ahmedabad plant is designed to manufacture glass products for building façades. HRS Aluglaze has entered into a turnkey construction agreement with Chavda Infra to execute civil, structural, and associated work for the factory building.  

The plant is projected to be completed within 15 months. According to Managing Director Rupesh Shah, this facility is expected to significantly increase production capacity, improve efficiency, and enhance quality control measures. 

Funding through Internal Accruals and IPO Proceeds 

The company is funding the project through a mix of internal accruals and project-specific funding. From the IPO proceeds of ₹53 crore, ₹18 crore has been allocated for capital expenditure, including the setup of the glass glazing line, and ₹19 crore towards working capital.  

This funding structure is planned in a way that avoids material impact on the company’s financial health. 

Read More: Auri Grow India Share Price Hits 5% Upper Circuit; Gets LoI from Hong Kong Based FII to Acquire 24% Stake! 

HRS Aluglaze Share Price Performance 

As of December 23, 2025, at 9:54 AM, HRS Aluglaze share price on BSE was trading at ₹153.14 up by 5.00% from the previous closing price. 

Conclusion 

HRS Aluglaze’s investment in a new glass glazing facility in Ahmedabad aims to improve its production capabilities and operational structure. With allocated funds from the IPO, the company is strategically positioning itself to handle larger and more intricate façade projects. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.